Details for Patent: 5,464,826
✉ Email this page to a colleague
Summary for Patent: 5,464,826
Title: | Method of treating tumors in mammals with 2',2'-difluoronucleosides |
Abstract: | A method of treating susceptible neoplasms in mammals comprising administering to a mammal in need of such treatment a pharmaceutically effective amount of a compound of the formula ##STR1## wherein: R.sup.1 is hydrogen; R.sup.2 is a base defined by one of the formulae ##STR2## X is C-R.sup.4 ; R.sup.3 is hydrogen; R.sup.4 is hydrogen, C.sub.1 -C.sub.4 alkyl, bromo, fluoro, chloro or iodo; and the pharmaceutically-acceptable salts thereof. |
Inventor(s): | Grindey; Gerald B. (Indianapolis, IN), Hertel; Larry W. (Indianapolis, IN) |
Assignee: | Eli Lilly and Company (Indianapolis, IN) |
Application Number: | 08/280,687 |
Patent Claim Types: see list of patent claims | Use; Compound; |
Drugs Protected by US Patent 5,464,826
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,464,826
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 92499 | ⤷ Try a Trial | |||
Australia | 5055585 | ⤷ Try a Trial | |||
Australia | 581269 | ⤷ Try a Trial | |||
Canada | 1264738 | ⤷ Try a Trial | |||
China | 1020194 | ⤷ Try a Trial | |||
China | 85109409 | ⤷ Try a Trial | |||
Cyprus | 1806 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |